BridgeMD
New treatment option for Cervical Pseudarthrosis
Official title Diagnostic Interest of Bone Tomoscintigraphy in the Search for Cervical Pseudarthrosis
ClinicalTrials.gov ID: NCT07140432
What this study is testing
- What it's testing
- Cervical pseudarthrosis is a classic complication and a challenge for challenge for spine surgeons. The rate of pseudarthrosis can range from 3 to 15%, and depend greatly on the patient, the approach the number of levels operated on.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 99
You may be able to join if
- Patients over 21 years of age
- Patients who have undergone cervical arthrodesis and are being treated at Clinique de la Sauvegarde or Clinique Convert
- Patients with a NDI clinical score at 1 year greater than 5
- Patient affiliated to/ or beneficiary of a Social Security scheme as definied by the law
You likely can't join if
- Patients whose clinical condition requires rapid treatment that can't wait for examinations to be carried out
- Pregnancy and breastfeeding
- Protected person (curatorship, guardianship, safeguard of justice)
- History of hypersensitivity to the active substance ( sodium oxidronate) or to any of its constituents
The study team makes the final eligibility decision.
Where it's taking place
- Bourg-en-Bresse, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bourg-en-Bresse, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.